ATXN2 and lung carcinoma: A study using sequencing analysis of exome and mRNA‐seq observed recurrent mutations of ATXN2 in nonsmokers patients with lung cancer, revealing the nonnegligible role of ATXN2 in the progress and prognosis of cancer patients.48